Thyroid cancer is the most rapidly rising incident cancer in women and the second most rapidly rising incident cancer in men in the United States. Project 2 will take a clinical and translational genetics approach to identify and characterize genes and their pathways that play a role in the initiation of heritable and sporadic follicular thyroid cancer (FTC) for the translational purposes of the earliest diagnosis. Towards these goals, we will take a 3-pronged approach to examine the earliest events in FTC initiation: germline initiating events in human heritable FTC, somatic initiating events in sporadic FTC and finally physiologic validation and mechanism resolution in a murine model. Specifically, we will utilize germline (inherited) predisposition to reflect the earliest initiating event by utilizing an heritable thyroid neoplasia disorder, Cowden syndrome (CS), which is a difficult-to-recognize, under-diagnosed autosomal dominant disorder characterized by follicular thyroid adenomas (FA), FTC and breast cancer. We plan to prospectively accrue 1,000 probands by set criteria, perform comprehensive PTEN alteration (DMA, RNA and protein) analysis and find the most parsimonious subset of clinical features by logistic regression analysis that will give a fixed likelihood of a PTEN alteration for purposes of referral as well as for purposes of correlating PTEN alteration and features associated with FTC vs FA risk. Second, we will identify and characterize the genes which when differentially expressed differentiate sporadic FTC from FA and independently validate our preliminary data which yielded a 3-gene combination, the latter mandatory before routine clinical application. This will allow the pre-surgical diagnosis of malignancy amongst all follicular thyroid nodules, something which remains extremely challenging on fine needle cytology. Importantly, if validated, our data would allow the pre-surgical diagnosis of FTC versus FA in the clinical arena. The genes which differentiate FTC from FA may play a role in the process of initiating sporadic FTC-genesis. Third, we propose a thyroid specific Ptenconditional knock-out murine model that will allow mechanism resolution for the first 2 aims on human heritable FTC and sporadic FTC initiation.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-GRB-S)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Ohio State University
United States
Zip Code
Nabhan, Fadi; Ringel, Matthew D (2016) Thyroid nodules and cancer management guidelines: comparisons and controversies. Endocr Relat Cancer :
Shirley, Lawrence A; McCarty, Samantha; Yang, Ming-Chen et al. (2016) Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target. Surgery 159:163-70
Tomsic, Jerneja; Fultz, Rebecca; Liyanarachchi, Sandya et al. (2016) HABP2 G534E Variant in Papillary Thyroid Carcinoma. PLoS One 11:e0146315
Harshman, Sean W; Canella, Alessandro; Ciarlariello, Paul D et al. (2016) Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers. J Proteomics 136:89-98
Kirschner, Lawrence S; Qamri, Zahida; Kari, Suresh et al. (2016) Mouse models of thyroid cancer: A 2015 update. Mol Cell Endocrinol 421:18-27
Justiniano, Steven E; McElroy, Joseph P; Yu, Lianbo et al. (2016) Genetic variants in thyroid cancer distant metastases. Endocr Relat Cancer 23:L33-6
Wang, Yanqiang; Li, Wei; Phay, John E et al. (2016) Primary Cell Culture Systems for Human Thyroid Studies. Thyroid 26:1131-40
Nagy, Rebecca; Ringel, Matthew D (2015) Genetic predisposition for nonmedullary thyroid cancer. Horm Cancer 6:13-20
Yehia, Lamis; Niazi, Farshad; Ni, Ying et al. (2015) Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer. Am J Hum Genet 97:661-76
Tomsic, Jerneja; He, Huiling; de la Chapelle, Albert (2015) HABP2 Mutation and Nonmedullary Thyroid Cancer. N Engl J Med 373:2086

Showing the most recent 10 out of 101 publications